Genpact Limited

NYSE:G

Information Technology Services

Technology
$41.98 -9.01%

-$2.73 today

Market cap
$7.12B
Beta
0.59
P/E (TTM)
8.2
EPS (TTM)
$3.34
Dividend yield
2.59%
52W Low $27.39High $48.64

Volume 2.37M

Average 2.81M

G Capital Expenditures

Cash spent on property, plant, equipment, and other long-term assets.

Genpact LimitedNYSE: G

Capital Expenditures · Q3 FY2026 · quarter ended Sep 2026

Capital expenditures growth accelerates

Q3 FY2026 capital expenditures of $16.7M (cash outflow) rose 2.2% year over year, ahead of the -14.0% change in trailing-twelve-month capital expenditures. Sequentially, it rose 160.5% from the prior quarter. Over 3 fiscal years it compounded at +12.9% a year.

Context

  • Capital expenditures amounted to 1.5% of revenue in FY2025, down 0.2 pp from a year earlier.
  • Capital expenditures grew in size in 2 of the last 3 fiscal years.

What to watch

Whether quarterly growth of +2.2% holds above the trailing-twelve-month pace of -14.0%.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterSep 2026
-$16.7M+160.5% QoQ
Last fiscal yearDec 2025
-$78.2M-8.3% YoY
LTMSep 2026
-$72.21M-14.0% YoY
Capital Expenditures past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+2.2%——
1 year-8.3%——
3-year CAGR+12.9%——
5-year CAGR——
10-year CAGR——

Capital Expenditures history

USD · from the cash flow

Latest · FY2025
(78.2M) USD
Year-over-year change
+8.3%

Capital Expenditures vs competitors

How G compares with its peers on the latest reported figures

  • Peers report in different currencies, so capital expenditures is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of -14.0% is the 9th highest of 11, against a peer median of +4.8%.
  • Capital expenditures amounts to 1.4% of revenue for G, versus a peer median of 2.0%.
G Competitors
Capital Expenditures for G and competitors
Company Period LTM YoY 3-year CAGR% of revenue
GDSGDS Holdings LimitedLTM Jun 2026CN¥4.43B CNY-3308.9%-15.6%36.2%
KDKyndryl Holdings, Inc.LTM Jun 2026$614M USD-1.9%-11.1%2.3%
INGMIngram Micro Holding CorporationLTM Jun 2026$135.02M USD-2.8%-1.3%0.2%
DLBDolby Laboratories, Inc.LTM Jun 2026$93.09M USD+238.7%+9.3%6.9%
FOURShift4 Payments, Inc.LTM Jun 2026$79.3M USD+4.9%-29.2%1.7%
GGenpact LimitedLTM Sep 2026$72.21M USD-14.0%+12.9%1.4%
EXLSExlService Holdings, Inc.LTM Jun 2026$52.67M USD+4.7%+5.5%2.4%
WAYWaystar Holding Corp.LTM Jun 2026$46.73M USD+79.5%+15.0%3.9%
SAICScience Applications International CorporationLTM Jul 2026$41M USD+5.1%+8.6%0.6%
ARWArrow Electronics, Inc.LTM Jul 2026$37.03M USD-56.3%+8.7%0.1%
CRUSCirrus Logic, Inc.LTM Jun 2026$26.49M USD+69.5%-27.5%1.3%
Peer median (excluding G) —+4.8%+2.1%2.0%

Competitors are the stored peer set for G. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income369.45M353.4M631.26M513.67M552.49M
Depreciation & Amortization167.57M129.52M103.99M69.78M94.96M
Deferred Income Tax(9.26M)(29.15M)(157.93M)36.61M19.94M
Stock-Based Compensation000089.62M
Change in Working Capital87.16M(147.08M)(182.24M)(100.18M)17.89M
Accounts Receivables(11.8M)(112.34M)(130.79M)(96.56M)(44.22M)
Inventory00000
Accounts Payables11.74M14.19M(8.22M)8.73M(6.42M)
Other Working Capital87.22M(48.92M)(43.24M)(12.36M)68.53M
Other Non-Cash Items79.37M136.98M95.74M95.54M37.95M
Operating Cash Flow694.28M443.67M490.81M615.42M812.86M
Capital Expenditures(57.25M)(54.39M)(58.78M)(85.24M)(78.2M)
Acquisitions (Net)(65.64M)17.8M(20.17M)2.64M(80.38M)
Purchases of Investments000(23.36M)(350M)
Sales of Investments142K00023.36M
Other Investing Activities0000(10.27M)
Investing Cash Flow(122.75M)(36.59M)(78.94M)(105.96M)(495.5M)
Debt Repayment49.04M(245.86M)(173.04M)(58.65M)309.86M
Common Stock Issued35.05M27.75M39.49M17.22M17.51M
Common Stock Repurchased(298.22M)(214.08M)(225.5M)(252.67M)(283.05M)
Dividends Paid(80.48M)(91.84M)(100.01M)(108.47M)(117.75M)
Other Financing Activities(38.28M)(47.38M)(23.93M)(22.28M)(33.38M)
Financing Cash Flow(332.88M)(571.4M)(483M)(424.85M)(106.82M)
Effect of Forex Changes(19.63M)(88.37M)8.03M(20.04M)(4.96M)
Net Change in Cash219.02M(252.69M)(63.1M)64.58M205.59M
Free Cash Flow637.03M389.28M432.04M530.19M734.65M

Genpact Limited

NYSE:G

Intrinsic Alpha fair value

Locked

Current Price

$41.98

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.